1. Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit

   Jacobs, M. S., Loef, B., Reidinga, A. C., Postma, M. J., Van Hulst, M. & Tieleman, R. G., Feb-2020, In : Open Heart. 7, 1, 7 p., 001226.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Anticoagulation in Atrial Fibrillation: Consideration for treatment and health economic aspects

   Jacobs, M., 2020, [Groningen]: University of Groningen. 232 p.

   Research output: Thesis › Thesis fully internal (DIV)

3. Zero-residual syringe als verpakkingsmateriaal voor bevacizumab als intravitreale injectie - Antwoord van de auteurs

   Jacobs, M. S., Hemminga, W. L., Woerdenbag, H. J., Bouma, M. & Moes, J. R., 20-Jan-2017, In : Pharmaceutisch Weekblad. 152, 3, 1 p.

   Research output: Contribution to journal › Letter › Academic › peer-review

4. Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review

   Jacobs, M. S., van Hulst, M., Adeoye, A. M., Tieleman, R. G., Postma, M. J. & Owolabi, M. O., Sep-2019, In : Global heart. 14, 3, p. 269-279

   Research output: Contribution to journal › Review article › Academic › peer-review

5. To Bridge or Not to Bridge: Modelling Periprocedural Anticoagulation Management

   van der Pol, S., Jacobs, M., Meijer, K., Piersma-Wichers, M. G., Tieleman, RG., Postma, M. & van Hulst, M., 3-Aug-2018, p. E417. 1 p.

   Research output: Contribution to conference › Poster › Academic

View all (13) »